Clinical trial
Evaluation of Dosing Interval of Higher Doses of Ranibizumab
NCT00533520 is registered in ClinicalTrials.gov with Brandon G. Busbee, MD as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of Dosing Interval of Higher Doses of Ranibizumab
- Lead sponsor
- Brandon G. Busbee, MD
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- September 30, 2007
- Completion date
- November 30, 2013
- Enrollment
- 37 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.